Be Prepared to Help Patients Switch to New Fluticasone/Salmeterol Inhalers

July 2017

New fluticasone/salmeterol inhalers for asthma (AirDuo, etc) will compete with Advair...and lead to questions about how to switch.

Teva is launching AirDuo (air-DOO-oh) RespiClick AND its authorized generic, fluticasone/salmeterol. The generic costs about $90/month...versus $285/month for AirDuo or up to $475/month for Advair.

But the new dry-powder inhalers are NOT AB-rated generics for Advair Diskus because they come in different strengths and devices. Plus AirDuo is not approved for COPD...and it's only for ages 12 and up.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote